Skip to content
Every investor in Global Payments Inc. (NYSE:GPN) should be aware of the most powerful shareholder groups......
Q3 2019 ALLETE Inc Earnings Call...
Aslan, which went public in May 2018, said its varlitinib, codenamed ASLAN001, failed in a pivotal study dubbed TreeTopp that evaluated the asset for biliary tract cancer. The multinational study evaluated 127 patients who failed first-line therapy. The median PFS was 2.83 months for varlitinib in combination with the chemotherapy drug capecitabine compared to 2.79 months for the control arm, Aslan said....
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is......
Q4 2019 Moog Inc Earnings Call...
Q4 2019 Clearfield Inc Earnings Call...
Today we will run through one way of estimating the intrinsic value of Greenlane Holdings, Inc. (NASDAQ:GNLN) by......
